ABBV - AbbVie Inc (Healthcare: Drug Manufacturers - General) Projected Earnings Date: 2026-05-06    (Delayed quote data   2026-02-10)
Last
 222.37		 Change
 ⇓ -0.85   (-0.38%)		 Volume
  6,041,649
Open
 223.85		 High
 225.81		 Low
 221.94
8EMA (Daily)
 221.94		 40EMA (Daily)
 222.67		 50EMA (Daily)
 222.86		 STO (Daily)
 65.635		 MACD Hist (Daily)
 0.421
8EMA (Weekly)
 222.653		 40EMA (Weekly)
 214.25		 50EMA (Weekly)
 210.83		 STO (Weekly)
 38.419		 MACD Hist (Weekly)
 -1.543
Company Profile
AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com